previous compound ID: 959 next compound
InChIKey: IMWZZHHPURKASS-UHFFFAOYSA-N
SMILES: CC1=CC(=CC(=C1)OCC2CNC(=O)O2)C

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"D Rotin" "B Kus" "J Liao" "R Robert" "GW Carlile" "J Goepp" "SD Macknight" "JW Hanrahan" "DY Thomas" "E Matthes"

chemical graph of compound 959





CID is 15459
synonyms found at PubChem are:
METAXALONE, 1665-48-1, Skelaxin, Metaxalon, Methaxalonum, Zorane, Methoxolone, 5-((3,5-Dimethylphenoxy)methyl)oxazolidin-2-one, Metazalone, Metazolone, Metaxolone, AHR-438, Metaxalonum [Latin], Metassalone [DCIT], Metaxalonum [INN-Latin], Metassalone, Metaxalona [INN-Spanish], Metaxalonum, Metaxalona, AHR 438, 2-Oxazolidinone, 5-[(3,5-dimethylphenoxy)methyl]-, 5-(3,5-Xyloloxymethyl)oxazolidin-2-one, Metaxalona [Spanish], CL 39,148, NSC 170959, 2-Oxazolidinone, 5-((3,5-xylyloxy)methyl)-, Metaxalone [USAN:INN:BAN], 5-((3,5-Dimethylphenoxy)methyl)-2-oxazolidinone, HSDB 3236, 5-((3,5-Xylyloxy)methyl)-2-oxazolidinone, 5-[(3,5-Xylyloxy)methyl]-2-oxazolidinone, 5-[(3,5-Dimethylphenoxy)methyl]-1,3-oxazolidin-2-one, EINECS 216-777-6, 5-[(3,5-dimethylphenoxy)methyl]oxazolidin-2-one, BRN 0884592, MLS003106749, CHEBI:6797, IMWZZHHPURKASS-UHFFFAOYSA-N, 5-[(3,5-Dimethylphenoxy)methyl]-2-oxazolidinone, 2-Oxazolidinone, 5-((3,5-dimethylphenoxy)methyl)-, NSC170959, 5-(3,5-dimethylphenoxymethyl)-1,3-oxazolidin-2-one, NCGC00095116-01, DSSTox_CID_3269, 2-Oxazolidinone, 5-[(3,5-xylyloxy)methyl]-, 5-(3,5-dimethylphenoxymethyl)-2-oxazolidinone, DSSTox_RID_76949, DSSTox_GSID_23269, CAS-1665-48-1, SR-05000001978, 5-((3,5-Dimethylphenoxy)methyl)-1,3-oxazolidin-2-one, .meta.Xalone, .meta.Zalone, .meta.Zolone, .meta.Xalon, Skelaxin (TN), Spectrum_001741, SpecPlus_000656, AC1Q6MIL, Metaxalone (USAN/INN), Spectrum2_000548, Spectrum3_001666, Spectrum4_000612, Spectrum5_001685, D0S5CH, AC1L25XO, Oprea1_438855, SCHEMBL34908, BSPBio_003451, KBioGR_001164, KBioSS_002221, DivK1c_006752, SPECTRUM1504229, SPBio_000595, GTPL7609, CHEMBL1079604, DTXSID3023269, Metaxalone, >=98% (HPLC), CTK8F0377, KBio1_001696, KBio2_002221, KBio2_004789, KBio2_007357, KBio3_002671, MolPort-003-666-548, HMS1922H07, HMS2093C22, Pharmakon1600-01504229, BCP28377, HY-B0678, KS-00000ZH8, Tox21_111428, WLN: T5MVOTJ D1OR C1 E1, 2-Oxazolidinone,5-xylyloxy)methyl]-, CCG-39592, MFCD00867700, NSC758703, STL450994, STL451511, AKOS009035315, Tox21_111428_1, CS-2910, DB00660, FS-3218, MCULE-3101469866, NSC-170959, NSC-758703, TRA0047745, NCGC00095116-02, NCGC00095116-03, NCGC00095116-05, BC220747, BR-61006, SMR001821638, SBI-0052859.P002, 2-Oxazolidinone,5-dimethylphenoxy)methyl]-, AB0063964, LS-100704, TR-035874, 4CH-009638, AM20060525, FT-0603568, M2578, ST24029254, 5-(3,5-dimethylphenoxy)methyl-2-oxazolidinone, C07934, D00773, S-2010, 5-((3,5-dimethylphenoxy)methyl)-2-oxazolidinon, AB00053284_04, 665M481, A810747, I06-0370, J-010295, SR-05000001978-1, SR-05000001978-3, BRD-A94709349-001-02-6, BRD-A94709349-001-03-4, 5-[(3,5-Dimethylphenoxy)methyl]-1,3-oxazolidin-2-one #, 5-{[(3,5-dimethylphenyl)oxy]methyl}-1,3-oxazolidin-2-one, 5-[(3,5-dimethylphenoxy)methyl]-4,5-dihydro-1,3-oxazol-2-ol, Metaxalone, United States Pharmacopeia (USP) Reference Standard, 105801-80-7